Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy.
Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy. J Cancer Surviv. 2023 02; 17(1):27-39.
View in:
PubMed
subject areas
Antineoplastic Agents
Cancer Survivors
Cisplatin
Hearing Loss
Humans
Hypercholesterolemia
Male
Prevalence
Risk Factors
Testicular Neoplasms
Tinnitus
authors with profiles
Mary Eileen Dolan